Biotech executives pull in some of health care’s biggest paydays, with Regeneron’s CEO sitting atop the pack

When it comes to executive compensation in the biotech and pharma sectors, it pays to be CEO of Regeneron Pharmaceuticals.

The company’s chief executive, Len Schleifer, took home $453 million in 2021, more than any other executive in the sector, according to a STAT analysis. That amount represents just less than the entire combined compensation — $478 million — of the next nine highest-paid biotech and pharma CEOs.

Tim Walbert, CEO of Horizon Therapeutics, took home $70 million last year, the second most among biopharma CEOs. Rounding out the top five: BridgeBio Pharma’s Neil Kumar ($63 million), Intellia Therapeutics’ John Leonard ($54 million), and Clay Siegall, the recently departed CEO of Seattle Genetics ($53.5 million).

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

Log In